 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 April 1999 | Volume 130 Issue 7 | Pages 545-553
Background: The benefits and risks of hormone replacement therapy (HRT) in postmenopausal women are not fully defined, and individual characteristics and preferences may influence decisions to use this therapy. Previous studies of postmenopausal women who use HRT have been conducted in local or highly selected cohorts or have not focused on current use.
Objective: To examine sociodemographic, clinical, and psychological factors associated with current use of HRT in a national population-based cohort.
Design: Random-digit telephone survey.
Setting: Probability sample of U.S. households with a telephone.
Participants: 495 postmenopausal women 50 to 74 years of age in 1995.
Measurements: Current use of HRT.
Results: Current use of HRT was reported by 37.6% of women (58.7% of those who underwent hysterectomy and 19.6% of those who did not undergo hysterectomy; P = 0.001). In multivariable analyses, use of HRT was more common among women in the South (adjusted odds ratio, 2.67 [95% CI, 1.08 to 6.59]) and West (odds ratio, 2.76 [CI, 1.01 to 7.53]) than the Northeast. Use was more common among college graduates (odds ratio, 3.72 [CI, 1.29 to 10.71]) and less common among women with diabetes mellitus (odds ratio, 0.17 [CI, 0.05 to 0.51]). Other cardiac risk factors and most psychological characteristics were not associated with HRT use.
Conclusions: Sociodemographic factors, such as region and education, may be more strongly associated with use of HRT than clinical factors, such as risk for cardiovascular disease. Future efforts should focus on understanding sociodemographic variations, defining which women are most likely to benefit, and targeting therapy to them.
Author and Article Information
From Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; and University of Massachusetts, Amherst, Massachusetts.
This study was presented at the plenary session of the 20th Annual Meeting of the Society of General Internal Medicine, Washington, D.C., 2 May 1997.
Acknowledgments: The authors thank the members and associates of the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development (Orville Gilbert Brim, PhD, Director) for their contributions to the design of this national survey; John Orav, PhD, for advice on statistical analyses; Mannie Liu, PhD, and Larry Zaborski, MA, MS, for assistance with computer programming; and Arnold M. Epstein, MD, MA, Matthew H. Liang, MD, MPH, and Barbara J. McNeil, MD, PhD, for helpful comments on an earlier draft of the manuscript.
Grant Support: By a grant from the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development (http://midmac.med.harvard.edu/home.html). Dr. Keating is a recipient of a National Research Service Award from the Agency for Health Care Policy and Research. Dr. Ayanian is a Generalist Physician Faculty Scholar of the Robert Wood Johnson Foundation.
Requests for Reprints: John Z. Ayanian, MD, MPP, Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115.
Current Author Addresses: Drs. Keating, Cleary, Zaslavsky, and Ayanian: Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115.
Dr. Rossi: 34 Stagecoach Road, Amherst, MA 01002. ARTICLE
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M.-N. Vercambre, A. Fournier, M.-C. Boutron-Ruault, F. Clavel-Chapelon, V. Ringa, and C. Berr Differential Dietary Nutrient Intake according to Hormone Replacement Therapy Use: An Underestimated Confounding Factor in Epidemiologic Studies? Am. J. Epidemiol., December 15, 2007; 166(12): 1451 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. T. Shaffer and C. A. Krantz Hormone Therapy and Cardiovascular Risk JAMA, August 8, 2007; 298(6): 623 - 624. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schutt, M. Kunz, and H. Blode Coadministration of Estradiol/Drospirenone and Indomethacin Does Not Cause Hyperkalemia in Healthy Postmenopausal Women: A Randomized Open-Label Crossover Study J. Clin. Pharmacol., June 1, 2007; 47(6): 774 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hing and K. M. Brett Changes in u.s. Prescribing patterns of menopausal hormone therapy, 2001-2003. Obstet. Gynecol., July 1, 2006; 108(1): 33 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Janghorbani, D. Feskanich, W. C. Willett, and F. Hu Prospective Study of Diabetes and Risk of Hip Fracture: The Nurses' Health Study Diabetes Care, July 1, 2006; 29(7): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Wilson, G. A. Chase, E. A. Chrischilles, and R. B. Wallace Hip Fracture Risk Among Community-Dwelling Elderly People in the United States: A Prospective Study of Physical, Cognitive, and Socioeconomic Indicators Am J Public Health, July 1, 2006; 96(7): 1210 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Benakanakere, C. Besch-Williford, J. Schnell, S. Brandt, M. R. Ellersieck, A. Molinolo, and S. M. Hyder Natural and Synthetic Progestins Accelerate 7,12-Dimethylbenz[a]Anthracene-Initiated Mammary Tumors and Increase Angiogenesis in Sprague-Dawley Rats. Clin. Cancer Res., July 1, 2006; 12(13): 4062 - 4071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Smigal, A. Jemal, E. Ward, V. Cokkinides, R. Smith, H. L. Howe, and M. Thun Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, May 1, 2006; 56(3): 168 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wei, D. L. Miglioretti, M. T. Connelly, S. E. Andrade, K. M. Newton, C. L. Hartsfield, K. A. Chan, and D. S. M. Buist Changes in Women's Use of Hormones After the Women's Health Initiative Estrogen and Progestin Trial by Race, Education, and Income J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Selvin, J. Coresh, S. H. Golden, L. L. Boland, F. L. Brancati, and M. W. Steffes Glycemic Control, Atherosclerosis, and Risk Factors for Cardiovascular Disease in Individuals With Diabetes: The Atherosclerosis Risk in Communities study Diabetes Care, August 1, 2005; 28(8): 1965 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Colditz Estrogen, Estrogen Plus Progestin Therapy, and Risk of Breast Cancer Clin. Cancer Res., January 15, 2005; 11(2): 909s - 917s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. M. Buist, K. M. Newton, D. L. Miglioretti, K. Beverly, M. T. Connelly, S. Andrade, C. L. Hartsfield, F. Wei, K A. Chan, and L. Kessler Hormone Therapy Prescribing Patterns in the United States Obstet. Gynecol., November 1, 2004; 104(5): 1042 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sharp, A. H. Cardy, S. C. Cotton, and J. Little CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE Review Am. J. Epidemiol., October 15, 2004; 160(8): 729 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Cognition and Dementia Obstet. Gynecol., October 1, 2004; 104(4_suppl): 25S - 40S. [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Harrison-Bernard Targeting of the Renin-Angiotensin System as an Adjunct to Estrogen Replacement Therapy Hypertension, October 1, 2004; 44(4): 390 - 391. [Full Text] [PDF]
|
|
|
|
|
|
H. D. Nelson Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review JAMA, April 7, 2004; 291(13): 1610 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Haas, C. P. Kaplan, E. P. Gerstenberger, and K. Kerlikowske Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results Ann Intern Med, February 3, 2004; 140(3): 184 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Allred, K. F. Allred, Y. H. Ju, L. M. Clausen, D. R. Doerge, S. L. Schantz, D. L. Korol, M. A. Wallig, and W. G. Helferich Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats Carcinogenesis, February 1, 2004; 25(2): 211 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Hersh, M. L. Stefanick, and R. S. Stafford National Use of Postmenopausal Hormone Therapy: Annual Trends and Response to Recent Evidence JAMA, January 7, 2004; 291(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E.D. Chilvers, R. C. Knibb, S. J. Armstrong, K. L. Woods, and R. F.A. Logan Post menopausal hormone replacement therapy and risk of acute myocardial infarction -- a case control study of women in the East Midlands, UK Eur. Heart J., December 2, 2003; 24(24): 2197 - 2205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Brett and C. A. Reuben Prevalence of Estrogen or Estrogen-Progestin Hormone Therapy Use Obstet. Gynecol., December 1, 2003; 102(6): 1240 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Mitchell, K. J. Cruickshanks, B. E. K. Klein, M. Palta, and D. M. Nondahl Postmenopausal Hormone Therapy and Its Association With Cognitive Impairment Arch Intern Med, November 10, 2003; 163(20): 2485 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Scheid, M. T. Coleman, and R. M. Hamm Do Perceptions of Risk and Quality of Life Affect Use of Hormone Replacement Therapy by Postmenopausal Women? J Am Board Fam Med, July 1, 2003; 16(4): 270 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Siraj, M. K. Gupta, and S. S. K. Reddy Raloxifene Causing Malabsorption of Levothyroxine Arch Intern Med, June 9, 2003; 163(11): 1367 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Lindamer, D. C. Buse, L. Auslander, J. Unutzer, S. J. Bartels, and D. V. Jeste A Comparison of Gynecological Variables and Service Use Among Older Women With and Without Schizophrenia Psychiatr Serv, June 1, 2003; 54(6): 902 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fenkci, V. Fenkci, M. Yilmazer, M. Serteser, and T. Koken Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension Hum. Reprod., April 1, 2003; 18(4): 866 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Riggs and L. C. Hartmann Selective Estrogen-Receptor Modulators -- Mechanisms of Action and Application to Clinical Practice N. Engl. J. Med., February 13, 2003; 348(7): 618 - 629. [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Jelinsky, H. A. Harris, E. L. Brown, K. Flanagan, X. Zhang, C. Tunkey, K. Lai, M. V. Lane, D. K. Simcoe, and M. J. Evans Global Transcription Profiling of Estrogen Activity: Estrogen Receptor {alpha} Regulates Gene Expression in the Kidney Endocrinology, February 1, 2003; 144(2): 701 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. Jordan The Ups and Downs of the Estrogen Receptor J. Clin. Oncol., January 1, 2003; 21(1): 3 - 4. [Full Text] [PDF]
|
|
|
|
|
|
B. T. Levy, J. M. Ritchie, E. Smith, T. Gray, and W. Zhang Physician Specialty Is Significantly Associated With Hormone Replacement Therapy Use Obstet. Gynecol., January 1, 2003; 101(1): 114 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Nelson, J. Rizzo, E. Harris, J. Cauley, K. Ensrud, D. C. Bauer, E. Orwoll, and for the Study of Osteoporotic Fractures Research G Osteoporosis and Fractures in Postmenopausal Women Using Estrogen Arch Intern Med, November 11, 2002; 162(20): 2278 - 2284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan Postmenopausal Hormone Replacement Therapy: Scientific Review JAMA, August 21, 2002; 288(7): 872 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laine Postmenopausal Hormone Replacement Therapy: How Could We Have Been So Wrong? Ann Intern Med, August 20, 2002; 137(4): 290 - 290. [Full Text] [PDF]
|
|
|
|
|
|
S. W. Fletcher and G. A. Colditz Failure of Estrogen Plus Progestin Therapy for Prevention JAMA, July 17, 2002; 288(3): 366 - 368. [Full Text] [PDF]
|
|
|
|
|
|
J. Miller, B. K.S. Chan, and H. D. Nelson Postmenopausal Estrogen Replacement and Risk for Venous Thromboembolism: A Systematic Review and Meta-Analysis for the U.S. Preventive Services Task Force Ann Intern Med, May 7, 2002; 136(9): 680 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Becker, A. K. Stuifbergen, and D. Gordon The Decision to Take Hormone Replacement Therapy among Women with Disabilities West J Nurs Res, April 1, 2002; 24(3): 264 - 281. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Hlatky, D. Boothroyd, E. Vittinghoff, P. Sharp, M. A. Whooley, and for the HERS Research Group Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy: Results From the Heart and Estrogen/Progestin Replacement Study (HERS) Trial JAMA, February 6, 2002; 287(5): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Schaumberg, J. E. Buring, D. A. Sullivan, and M. R. Dana Hormone Replacement Therapy and Dry Eye Syndrome JAMA, November 7, 2001; 286(17): 2114 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Shlipak, B. G. Angeja, A. S. Go, P. D. Frederick, J. G. Canto, and D. Grady Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women Circulation, November 6, 2001; 104(19): 2300 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Manson and K. A. Martin Postmenopausal Hormone-Replacement Therapy N. Engl. J. Med., July 5, 2001; 345(1): 34 - 40. [Full Text] [PDF]
|
|
|
|
|
|
A. Ferrara, A. J. Karter, L. M. Ackerson, J. Y. Liu, and J. V. Selby Hormone Replacement Therapy Is Associated With Better Glycemic Control in Women With Type 2 Diabetes: The Northern California Kaiser Permanente Diabetes Registry Diabetes Care, July 1, 2001; 24(7): 1144 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Nicodemus and A. R. Folsom Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women Diabetes Care, July 1, 2001; 24(7): 1192 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Glazier and M. A. Bowman A Review of the Evidence for the Use of Phytoestrogens as a Replacement for Traditional Estrogen Replacement Therapy Arch Intern Med, May 14, 2001; 161(9): 1161 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. LeBlanc, J. Janowsky, B. K. S. Chan, and H. D. Nelson Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis JAMA, March 21, 2001; 285(11): 1489 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Z. Ayanian Increased Mortality among Middle-Aged Women after Myocardial Infarction: Searching for Mechanisms and Solutions Ann Intern Med, February 6, 2001; 134(3): 239 - 241. [Full Text] [PDF]
|
|
|
|
|
|
T. E. C. Workshop Group Continuation rates for oral contraceptives and hormone replacement therapy Hum. Reprod., August 1, 2000; 15(8): 1865 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Freedman, F. S. Kaplan, W. B. Bilker, B. L. Strom, and R. A. Lowe Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*{{dagger}} J. Bone Joint Surg. Am., August 1, 2000; 82(8): 1063 - 1063. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Armstrong, S. Popik, C. Guerra, and P. A. Ubel Beliefs about Breast Cancer Risk and Use of Postmenopausal Hormone Replacement Therapy Med Decis Making, July 1, 2000; 20(3): 308 - 313. [Abstract] [PDF]
|
|
|
|
 |
|
 Y.-S. Chung, M.-D. Lee, S.-K. Lee, H.-M. Kim, and L. A. Fitzpatrick HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1137 - 1142. [Abstract] [Full Text]
|
|
|
|
|
|
P. N. Singh Hormone Replacement Therapy in Postmenopausal U.S. Women Ann Intern Med, November 16, 1999; 131(10): 791 - 791. [Full Text] [PDF]
|
|
|
|
|
|
M. T. Connelly, N. Ferrari, N. Hagen, and T. S. Inui Patient-Identified Needs for Hormone Replacement Therapy Counseling: A Qualitative Study Ann Intern Med, August 17, 1999; 131(4): 265 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Rochon and J. H. Gurwitz Prescribing for Seniors: Neither Too Much nor Too Little JAMA, July 14, 1999; 282(2): 113 - 115. [Full Text] [PDF]
|
|
|
|
 |
|
 Hormone Replacement Therapy in the United States Journal Watch Cardiology, May 21, 1999; 1999(521): 8 - 8. [Full Text]
|
|
|
|
 |
|
 Not Even Half of Menopausal Women Take Hormones Journal Watch Women's Health, May 1, 1999; 1999(501): 5 - 5. [Full Text]
|
|
|
|
 |
|
 Fewer Than Half of Menopausal Women Take HRT Journal Watch (General), April 16, 1999; 1999(416): 1 - 1. [Full Text]
|
|
|
|
|
|
J. Daley Medical Uncertainty and Practice Variation Get Personal: What Should I Do about Hormone Replacement Therapy? Ann Intern Med, April 6, 1999; 130(7): 602 - 604. [Full Text] [PDF]
|
|
Article
